Canada Markets closed

Merck & Co., Inc. (MRK)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
83.05+0.45 (+0.54%)
At close: 4:02PM EST
Sign in to post a message.
  • M
    Matt
    Take the Covid 19 name out of the equation and replace it with cancer. A pill just reduced mortality rate by 90 percent. Why are we focused on the hospitalizations? What’s the goal here? If you treat Covid like cancer the focus shouldn’t be to not hospitalize but to not die of Covid.
  • G
    Glenn
    I figure MRK would be up with the new virus and good chance their pill either will work or can be altered like the vaccine.?
  • P
    PovD
    CNBC: Merck Covid pill reduces death and hospitalization risk by 30%, updated study finds. Previous rate was 50%.

    https://www.cnbc.com/video/2021/11/26/merck-covid-pill-reduces-death-hospitalization-risk-by-30-percent-updated-study-finds.html
  • f
    frank
    starting to wonder why this isnt trading higher with FDA meeting coming up on 11/30!..... thoughts everyone
  • F
    Francis
    "9 deaths in control group. One death in treatment group" hahaha imagine if people understood what they were talking about. 1433 patients total with only 30 % efficacy, if I do the math that's..... ONLY 55 % statistical power. Look at the bigger picture, it will NOT be used for mild to moderate and potentially get EUA for Severe but with more problems to arise Mercks drug will not last long on the drug market.
  • G
    Greg
    Would expect MRK to recover since Buffett’s dump first week in November. Big $ gets info before the small investors. Something is wrong here
  • R
    Rajen
    Canada approved Keytruda this morning for another indication.This was up by 2% today but gave 1% back as some trader sold it for small gain.If they approve covid-19 pill on 29th this will be $87-$88 by end of the month.
  • L
    LEWIS
    I noticed MRK has not declared their dividend. They usually raise it about this time. Any thoughts?
  • G
    Greg
    I took vaccines 1 & 2 last Feb and March. Am I protected?
  • G
    George
    So, we get a bit of news that the effectiveness is lower, but when you're dealing with statistics the numbers can sound earth shattering. The reality plays out differently only when there is nothing else to compete. Merk has been forthcoming and that sheds a bright light on their integrity. Will the competition do the same? In places where it is mostly impossible to due transfusions this is still the best option. these places are in the majority so I think the drop is more panic and uneducated reaction then warranted. So, it will take a bit of time till the truth over takes the folly. This is still a wonderful breakthrough for attacking Covid and in rural and poor areas this discovery will continue to be good news. The competition has yet to be fully forth coming and the news may be somewhere in the same ballpark.
  • k
    kinshuk
    Forget effectiveness of the covid pill. As long as the orders keep coming, we make money. The orders have not stopped coming so there is nothing to worry. If anything things are looking positive, orders will keep coming
  • r
    raymond
    pfizer appied for an EAU for its vaccine and 21 days later got approval.
    merck applied on october 11 and wont have its hearing until november 30th
    hospitals are full around here...people are dying.....whats up with bidens fda?
  • B
    BobDole
    $MRNA conversation
    What's interesting is this will only ensure the FDA does emergency use approval of $MRK and $PFE COVID pills even sooner because the pill works on all variants, unlike vaccines. WHEN (not IF) that happens, vaccine stocks are going to tank big time. Gotta love this market.
  • E
    Ez$
    $SLS conversation
    While all the conman beg for us to Sell them our shares keep in Mind it is only a Matter of time for the Phase 3 data - 7 ish months for 1,000's of Percent Gain. My Est is a $3B Market Cap at that time. $7’s gonna be $70 and then $170 in less than 7 months time - Aml P3 Priceless Gps $MRK $BMY Trial Results 5/6 weeks, Nps $Rhhby $Glsi type results due Now, Litigation Finalized, Today, Licensing cleared and Imminent - Lots of Action for this low float baby bio coming in Nov, Dec, and January
  • J
    Jros
    Let me give everyone some stats. When Pfizer studied those who were given treatment within 5 days, 1 percent were hospitalized in the treatment group versus 6.7 in the placebo. From an absolute risk standpoint, that is equivalent to a 6.7 - 1 = 5.7 percentage point difference. When Merck studied those given treatment within 5 days of symptoms, 7.3 percent in the treatment group were hospitalized versus 14.1 percent in the placebo group. The absolute risk difference was 14.1 - 7.3 = 6.8. Therefore, Merck’s drug is actually more effective with their study population than Pfizer’s drug is with their study population. That’s the only thing we can conclude since it is obvious that Merck’s and Pfizer’s populations weren’t the same. Companies like to use relative ratios to report their efficacy because it makes the results look better. But absolute risk is actually the right way to compare. This is coming from a mathematician and statistician.
  • f
    frank
    if approved what is price target???
  • e
    edward
    When should we expect the FDA to green light EUA?
  • M
    Matt
    Weird how they portrayed that info this morning. Reduced hospitalization rate by 30 percent which is still quite significant but deaths it reduced by almost 100 percent.
  • T
    Todd
    US agreeing to buy $1billion more Covid pills. Good for Pfe saving people but Covid pill needs taken with aids treatment and has a lot more stomach upset side effect. EU approval upcoming. MRK asked for emergency approval for reasons we all know. Shameful FDA panel putting off voting till Nov 30th while UK (generally their usually the hardest to get passed) the rest of the world is full steam ahead...
  • E
    Ez$
    $SLS conversation
    While all the conman beg for us to Sell them our shares keep in Mind it is only a Matter of time for the Phase 3 data - 7 ish months for 1,000's of Percent Gain. My Est is a $3B Market Cap at that time. $7’s gonna be $70 and then $170 in less than 7 months time - Aml P3 Priceless Gps $MRK $BMY Trial Results 5/6 weeks, Nps $Rhhby $Glsi type results due Now, Litigation Finalized, Today, Licensing cleared and Imminent - Lots of Action for this low float baby bio coming in Nov, Dec, and January